Skip to content

Feasibility of neurocognitive testing in healthy children

Feasibility of neurocognitive testing in healthy children - Feasibility of neurocognitive testing in healthy children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31940
Enrollment
16
Registered
2007-10-24
Start date
2007-10-20
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

De gebruikte neurocognitieve testen zijn bruikbaar als biomarker voor centrale effecten van geneesmiddelen in bredere zin. Bij deze pilot is er geen sprake van een specifieke aandoening die bestudeerd wordt. none

Interventions

None listed

Sponsors

Centre for Human Drug Research
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: •Age 8-12 years •Written informed consent from parents having parental responsibility or from the legal guardian. In the case of a child aged 12 years or older the written informed consent of the child is needed in addition to that of parents having responsibility/legal guardian, in the case of a child aged younger than 12 years, assent needs to be provided.

Exclusion criteria

Exclusion criteria: •Any known psychiatric diagnosis (e.g. autism, oppositional defiant disorder, ADHD) •Dyslexia •Learning disability •Significant behavioural problems •Use of medication •Preterm birth

Design outcomes

Primary

MeasureTime frame
Results of Neurocognitive tasks: - Stroop color-word task - Adaptive tracking - Smooth eye pursuit - Saccadic Eye movements - Finger tapping - Body sway Results of a short questionnaire taken after completion of the Neurocognitive tasks.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)